Summary by Futu AI
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 883 shares of common stock on 02/26/2024, as per the latest filing. The shares, valued at an aggregate market value of $375,893.1, were acquired on 02/24/2024 as performance shares, a form of compensation from the issuer. This transaction follows a series of sales over the past three months, where Morrow sold a total of 2,915 shares, amounting to gross proceeds of $1,227,277.68. The planned sale is in line with a notice dated 02/26/2024, with the original plan adopted on 08/22/2023.